HomeCompareTERCF vs MRK

TERCF vs MRK: Dividend Comparison 2026

TERCF yields 43.73% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TERCF wins by $6.56M in total portfolio value
10 years
TERCF
TERCF
● Live price
43.73%
Share price
$0.07
Annual div
$0.03
5Y div CAGR
18.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.62M
Annual income
$3,641,629.77
Full TERCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — TERCF vs MRK

📍 TERCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTERCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TERCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TERCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TERCF
Annual income on $10K today (after 15% tax)
$3,717.20/yr
After 10yr DRIP, annual income (after tax)
$3,095,385.30/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, TERCF beats the other by $3,086,788.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TERCF + MRK for your $10,000?

TERCF: 50%MRK: 50%
100% MRK50/50100% TERCF
Portfolio after 10yr
$3.34M
Annual income
$1,825,871.78/yr
Blended yield
54.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TERCF
No analyst data
Altman Z
-0.4
Piotroski
2/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TERCF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTERCFMRK
Forward yield43.73%2.81%
Annual dividend / share$0.03$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR18.6%32.7%
Portfolio after 10y$6.62M$57.7K
Annual income after 10y$3,641,629.77$10,113.78
Total dividends collected$6.24M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TERCF vs MRK ($10,000, DRIP)

YearTERCF PortfolioTERCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,887$5,186.59$11,213$373.04+$4.7KTERCF
2$26,132$9,133.00$12,667$512.06+$13.5KTERCF
3$44,612$16,651.39$14,439$708.14+$30.2KTERCF
4$79,244$31,509.30$16,640$988.16+$62.6KTERCF
5$146,829$62,037.47$19,432$1,394.07+$127.4KTERCF
6$284,515$127,408.44$23,057$1,992.90+$261.5KTERCF
7$578,080$273,648.56$27,889$2,894.79+$550.2KTERCF
8$1,234,823$616,277.38$34,518$4,286.29+$1.20MTERCF
9$2,780,390$1,459,129.57$43,912$6,494.35+$2.74MTERCF
10$6,616,647$3,641,629.77$57,714$10,113.78+$6.56MTERCF

TERCF vs MRK: Complete Analysis 2026

TERCFStock

TerraCom Limited engages in the exploration and extraction of coal in Australia and South Africa. The company explores for hard and soft coking, thermal, and PCI coal. Its flagship property is the Blair Athol coal mine located in Clermont, Queensland. The company also holds interests in the Northern Galilee project comprising the Hughenden and the Pentland properties covering an area of approximately 2,160 square kilometers; the Clyde Park project that covers an area of approximately 133 square kilometers located in the Galilee Basin, Queensland; and the Springsure project covering an area of approximately 1,178 square kilometers located in the Central-Western Bowen basin coal mining district, Queensland. In addition, it holds interests in the Kangala Colliery property; the New Clydesdale Colliery project; the Berenice project; the Ubuntu Colliery; the North Block Complex Colliery project; the Arnot South; the Cygnus project; and the Eloff project located in South Africa. The company was formerly known as Guildford Coal Limited and changed its name to TerraCom Limited in November 2015. TerraCom Limited was founded in 2009 and is based in Clermont, Australia.

Full TERCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TERCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TERCF vs SCHDTERCF vs JEPITERCF vs OTERCF vs KOTERCF vs MAINTERCF vs JNJTERCF vs ABBVTERCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.